PSYCHOLOGY / RESEARCH LETTER
 
TOPICS
REFERENCES (15)
1.
Bueno-Notivol J, Gracia-Garcia P, Olaya B, et al. Prevalence of depression during the COVID-19 outbreak: a meta-analysis of community-based studies. Int J Clin Health Psychol 2021; 21: 100196.
 
2.
Akkaya-Kalayci T, Kothgassner OD, Wenzel T, et al. The impact of the COVID-19 pandemic on mental health and psychological well-being of young people living in Austria and Turkey: a multicenter study. Int J Environ Res Public Health 2020; 17: 9111.
 
3.
Zhang SX, Miller SO, Xu W, et al. Meta-analytic evidence of depression and anxiety in eastern Europe during the COVID-19 pandemic. Eur J Psychotraumatol 2022; 13: 2000132.
 
4.
Folayan MO, Ibigbami O, El Tantawi M, et al. Associations between mental health challenges, sexual activity, alcohol consumption, use of other psychoactive substances and use of COVID-19 preventive measures during the first wave of the COVID-19 pandemic by adults in Nigeria. BMC Public Health 2023; 23: 1506.
 
5.
Jones CM, McCance-Katz EF. Co-occurring substance use and mental disorders among adults with opioid use disorder Drug Alcohol Depend 2019; 197: 78-82.
 
6.
Pérez T, Pardo MC, Cabellos Y, et al. Mental health and drug use in college students: Should we take action? J Affect Disord 2023; 338: 32-40.
 
7.
Newport K, Bishop L, Donnan J, et al. The COVID-19 pandemic and cannabis use in Canada-a scoping review. J Cannabis Res 2023; 5: 31.
 
8.
Boehnke KF, Litinas E, Worthing B, et al. Communication between healthcare providers and medical cannabis patients regarding referral and medication substitution. J Cannabis Res 2021; 3: 2.
 
9.
Armour M, Sinclair J, Chalmers KJ, et al. Self-management strategies amongst Australian women with endometriosis: a national online survey. BMC Complement Altern Med 2019; 19: 17.
 
10.
van Laar MW, Oomen PE, van Miltenburg CJA, et al. Cannabis and COVID-19: reasons for concern. Front Psychiatry 2020; 11: 601653.
 
11.
Cox C. The Canadian Cannabis Act legalizes and regulates recreational cannabis use in 2018. Health Policy 2018; 122: 205-9.
 
12.
Destrée L, Amiet D, Carter A, et al. Exploring the association of legalisation status of cannabis with problematic cannabis use and impulsivity in the USA. Drugs Context 2018; 7: 212541.
 
13.
Hindley G, Beck K, Borgan F, et al. Psychiatric symptoms caused by cannabis constituents: a systematic review and meta-analysis. Lancet Psychiatry 2020; 7: 344-53.
 
14.
Armour M, Sinclair J, Cheng J, et al. Endometriosis and cannabis consumption during the COVID-19 pandemic: an international cross-sectional survey. Cannabis Cannabinoid Res 2022; 7: 473-81.
 
15.
Vanderbruggen N, Matthys F, Van Laere S, et al. Self-reported alcohol, tobacco, and cannabis use during COVID-19 lockdown measures: results from a web-based survey. Eur Addict Res 2020; 26: 309-15.
 
eISSN:1896-9151
ISSN:1734-1922
Journals System - logo
Scroll to top